Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | PPP5C | P53041 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Methyl Pyrrolidine (Nmp) SCHEMBL28432798 | 0.88 | CYP1A2 (0.42) | CYP1A2TDP1ACHEPAOXCA12 | |
| Acetamide SCHEMBL4743096 | 0.87 | CYP1A2 (0.60) | CYP1A2TDP1PAOXCA12CA2 | |
| Bicarbonate SCHEMBL16668956 | 0.86 | CYP1A2 (0.58) | CYP1A2TDP1PAOXCA12CA2 | |
| Methylpiperazine SCHEMBL8607131 | 0.81 | CA2 (0.39) | CYP1A2TDP1ACHECA12CA2 | |
| Bicarbonate SCHEMBL16668986 | 0.79 | CYP1A2 (0.46) | CYP1A2TDP1PAOXCA12CA2 | |
| SCHEMBL189872 | 0.79 | CYP1A2 (0.59) | CYP1A2TDP1HTR1AALDH1A1POLB | |
| Carbamic Acid SCHEMBL15287821 | 0.79 | SETD7 (0.36) | CYP1A2TDP1ACHEKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL3228161 | 0.77 | CYP1A2 (0.56) | CYP1A2TDP1HTR1APOLBHTT | |
| SCHEMBL28031164 | 0.77 | CYP1A2 (0.44) | CYP1A2TDP1PAOXCA12CA2 | |
| Hydrochloric Acid SCHEMBL7438943 | 0.77 | CYP1A2 (0.56) | CYP1A2TDP1HTR1APOLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220339150-A1 | ENDOCANNABINOID SYSTEM-TARGETING PRODRUGS AND THERAPEUTIC USES THEREOF | MEDIPURE PHARMACEUTICALS INC (CA) | 2022-10-27 | — | — | US | disclosed |
| WO-2022213200-A1 | ENDOCANNABINOID SYSTEM-TARGETING PRODRUGS AND THERAPEUTIC USES THEREOF | Medipure Pharmaceuticals Inc. (CA) | 2022-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339150-A1 | ENDOCANNABINOID SYSTEM-TARGETING PRODRUGS AND THERAPEUTIC USES THEREOF | CNR2, CNR1, GPR68 | CYP1A2 85/4885TDP1 2155/4885ACHE 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.